Olmetec: new angiotensin II blocker coming soonSchering-Plough will soon be launching Olmetec and Olmetec Plus for the treatment of mild to moderate hypertension. B.C. drug substitution plan cost more than it saved: study Pantoprazole: preferred PPI in patients taking clopidogrel A new Canadian Medical Association Journal study suggests that the interaction between clopidogrel and proton pump inhibitors is clinically significant. C. DIFFICILE: Fecal transplantation a stunning success in treating recurrent C.difficile Transfer of stool from donor may sound objectionable, but patients grateful for relief from infection-related diarrhea Team approach weans seniors off sedatives New hypertension guidelines target diabetes and unsafe drug combo POLITICS: Data may deserve critical eye, but kudos for effort, too DOCTOR TO DOCTOR: Atrial fibrillation explained (again) Doctor shortage (and early retirement) over thanks to the stock market Average physician-held financial portfolio has shrunk by approximately 30% in the last year Canada in brief: Doctor dies in train-auto crash First Previous 2223 2224 2225 2226 2227 Next Last
